Author

K. Mishkin

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Real-World Treatment Utilization and Patterns of Adjuvant Olaparib for Early-Stage Breast Cancer: Insights from the Komodo Research Database

Simple Summary Breast cancer is the most common cancer among women, and those carrying inherited mutations in their BRCA1 or BRCA2 genes face a significantly higher lifetime risk of developing the disease. Olaparib, a targeted therapy that blocks proteins that cancer cells rely on for DNA repair, was approved in 2022 f...

F. Batalini, Qi-Xin Li, J. Hayes et al. · Current Oncology · 0 citations

Review Open access Sep 2026

Factors influencing oncologists’ decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer

Introduction With advances in targeted early breast cancer (eBC) treatment, research is needed to understand the factors influencing biomarker testing and respective treatment selection among physicians in routine clinical practice. The purpose of this study was to evaluate factors influencing oncologist decisions for...

Qi-Xin Li, M. J. Cambron-Mellott, Xiao-Qing Xu et al. · Frontiers in Oncology · 0 citations